Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1987 1
1988 5
1989 6
1990 10
1991 14
1992 14
1993 20
1994 24
1995 28
1996 21
1997 40
1998 31
1999 35
2000 29
2001 25
2002 30
2003 18
2004 23
2005 23
2006 32
2007 18
2008 21
2009 11
2010 22
2011 15
2012 18
2013 9
2014 20
2015 13
2016 7
2017 7
2018 12
2019 16
2020 13
2021 17
2022 9
2023 8
2024 8
2025 7
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

658 results

Results by year

Filters applied: . Clear all
Page 1
Fosinopril.
[No authors listed] [No authors listed] 2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999858 Free Books & Documents. Review.
Because no information is available on the use of fosinopril during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant....
Because no information is available on the use of fosinopril during breastfeeding, an alternate drug may be preferred, especially whi …
Fosinopril.
[No authors listed] [No authors listed] 2018 Feb 6. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Feb 6. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644120 Free Books & Documents. Review.
Fosinopril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Fosinopril is associated with a low rate of transient serum aminotransferase elevations during therapy and has been linked to rare instances of acut …
Fosinopril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Fosinopril …
Fosinopril.
Alessi K, Patel P, Parmar M. Alessi K, et al. 2024 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2024 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 32119367 Free Books & Documents.
Fosinopril belongs to the class of angiotensin-converting enzyme (ACE) inhibitors used in cardiovascular conditions for nearly 3 decades. ...Being a competitive inhibitor of ACE, fosinopril prevents the conversion of angiotensin I to angiotensin II-a powerful vasoco …
Fosinopril belongs to the class of angiotensin-converting enzyme (ACE) inhibitors used in cardiovascular conditions for nearly 3 deca …
Fosinopril. Clinical pharmacokinetics and clinical potential.
Shionoiri H, Naruse M, Minamisawa K, Ueda S, Himeno H, Hiroto S, Takasaki I. Shionoiri H, et al. Clin Pharmacokinet. 1997 Jun;32(6):460-80. doi: 10.2165/00003088-199732060-00003. Clin Pharmacokinet. 1997. PMID: 9195116 Review.
Fosinopril is a phosphorus-containing ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor. ...The hypotensive effect of the combination of fosinopril and a diuretic is synergistic. Pharmacokinetic interactions with fosinopril are unlikely in pat …
Fosinopril is a phosphorus-containing ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor. ...The hypotensive effect of …
Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure.
Davis R, Coukell A, McTavish D. Davis R, et al. Drugs. 1997 Jul;54(1):103-16. doi: 10.2165/00003495-199754010-00012. Drugs. 1997. PMID: 9211084 Review.
Fosinopril is the prodrug of the active diacid ACE inhibitor fosinoprilat. In patients with heart failure, fosinopril reduces pulmonary capillary wedge pressure, mean arterial blood pressure, mean right atrial pressure and heart rate, and increases stroke volume ind …
Fosinopril is the prodrug of the active diacid ACE inhibitor fosinoprilat. In patients with heart failure, fosinopril reduces …
Fosinopril: a new generation of angiotensin-converting enzyme inhibitors.
Weber MA. Weber MA. J Cardiovasc Pharmacol. 1992;20 Suppl 10:S7-12. doi: 10.1097/00005344-199200101-00003. J Cardiovasc Pharmacol. 1992. PMID: 1283429 Review.
Fosinopril administration leads to complete inhibition of plasma ACE activity for 12-24 h. ...The incidence of adverse events does not differ significantly between fosinopril- and placebo-treated patients. Fosinopril represents a clinically useful agent for t …
Fosinopril administration leads to complete inhibition of plasma ACE activity for 12-24 h. ...The incidence of adverse events does no …
Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
Wagstaff AJ, Davis R, McTavish D. Wagstaff AJ, et al. Drugs. 1996 May;51(5):777-91. doi: 10.2165/00003495-199651050-00006. Drugs. 1996. PMID: 8861547 Review.
Fosinopril is a phosphinic acid derivative which undergoes rapid hydrolysis after oral administration to the active diacid ACE inhibitor fosinoprilat. ...The combination of fosinopril/chlorthalidone 20 to 40/25 mg/day was as effective as propranolol/chlorthalidone 8 …
Fosinopril is a phosphinic acid derivative which undergoes rapid hydrolysis after oral administration to the active diacid ACE inhibi …
Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.
Murdoch D, McTavish D. Murdoch D, et al. Drugs. 1992 Jan;43(1):123-40. doi: 10.2165/00003495-199243010-00009. Drugs. 1992. PMID: 1372856 Review.
Generally, fosinopril is well tolerated and adverse events associated with the drug are usually mild and similar to those associated with other ACE inhibitors. Thus, fosinopril appears to be a useful alternative to certain 'established' agents used for treating pati …
Generally, fosinopril is well tolerated and adverse events associated with the drug are usually mild and similar to those associated …
Fosinopril mediates antitumor efficacy by inducing GSDME-dependent pyroptosis in NSCLC.
Gao Y, Zhai X, Zhang C, Zhao H, Ji B, Sun R, Du X, Du Y, Gao S, Zhang Y, Wang T. Gao Y, et al. Cell Death Discov. 2025 Nov 21;11(1):540. doi: 10.1038/s41420-025-02791-4. Cell Death Discov. 2025. PMID: 41271670 Free PMC article.
Here, we explore the potential anti-NSCLC effects of fosinopril in vitro and in vivo and its action mechanisms. The antiproliferative effects of fosinopril on NSCLC cells were assessed through the A549 and H1299 cell lines. ...Fosinopril significantly inhibit …
Here, we explore the potential anti-NSCLC effects of fosinopril in vitro and in vivo and its action mechanisms. The antiproliferative …
Fosinopril: an overview.
Guthrie R. Guthrie R. Am J Cardiol. 1993 Dec 30;72(20):22H-24H. doi: 10.1016/0002-9149(93)91051-i. Am J Cardiol. 1993. PMID: 8285178
It is in this context that the clinical data on fosinopril will be reviewed. Fosinopril has several intriguing features, among them a unique chemical structure and elimination profile. In addition, preliminary data on cardiac effects and on risk for cough are provoc …
It is in this context that the clinical data on fosinopril will be reviewed. Fosinopril has several intriguing features, among …
658 results